Skip to main content
. 2014 Feb 10;28(2):554–563. doi: 10.1111/jvim.12313

Table 6.

Factors associated with disease‐free interval (DFI), survival times, or both (ST) in univariable analysis for the modified intent‐to‐treat analysis.

Variable DFI ST
HR (95% CI) P value HR (95% CI) P value
Age at diagnosis (years) 0.99 (0.95, 1.04) .69 1.05 (1.01, 1.09) .02
Body weight (kg) 1.02 (1.01, 1.03) <.001 1.02 (1.01, 1.03) <.001
Pure breed dog 1.40 (1.04, 1.87) .027 1.35 (1.06, 1.72) .016
Proximal humeral tumor 1.50 (1.16, 1.93) .0017 1.49 (1.20, 1.85) <.001
ALP (continuous) 1.001 (1.000, 1.001) .0084 1.000 (1.000, 1.001) .048
Lymphocyte count (continuous) 0.82 (0.66, 1.02) .074 0.78 (0.65, 0.93) .006
Treatment delays (continuous) 0.85 (0.76, 0.96) .007 0.92 (0.83, 1.00) .06
Summation dose intensity 2.82 (1.05, 7.63) .04 1.84 (0.82, 4.14) .14
Treatment following development of metastatic disease 1.89 (1.41, 2.54) <.0001

HR, hazard ratio.